Clinical trials: Blepharitis, open to volunteers
Anterior Blepharitis
Ocular Dysbiosis in Eyelid Disease
The goal of this observational study is to determine the presence and prevalence of fungal organisms in four distinct blepharitis populations.
- Trial name
- ODYSSEY (NCT07869498)
- Where
- 5 sites in United States
- Volunteers
- 60 people
- Sponsor
- Brent Kramer
Anterior Blepharitis
Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study
The goal of this clinical trial is to learn if Natacyn works to reduce or eliminate laboratory-confirmed fungal organisms in subjects with fungal-positive blepharitis identified in a previous study. asthma in adults.
- Trial name
- CLEAR (NCT07856680)
- Testing
- NATACYN®
- Where
- 5 sites in United States
- Volunteers
- 60 people
- Sponsor
- Brent Kramer
Blepharitis
Evaluation of SUMMIT BRUSH in Treatment of Blepharitis
Dry Eye Disease (DED) is a multifactorial disease that affects ~15-30 million people in the USA alone. It creates an enormous societal and economic burden, decreases productivity in the workplace, and affects the quality of lives…
- Trial name
- NCT04603222
- Testing
- SUMMIT BRUSH, Ocusoft Lid Scrub Original Foaming Eyelid Cleanser
- Where
- 3 sites in United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Notre Dame
Demodex Blepharitis
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
This is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-321 in patients with Demodex blepharitis.
- Trial name
- NCT07400965
- Testing
- GLK-321 low dose BID, GLK-321 mid dose BID, GLK-321 high dose BID
- Where
- United States
- Volunteers
- 250 people
- Sponsor
- Glaukos Corporation
Artifical Intelligence, Cataract
Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye
This is a multi-center, cross-sectional study evaluating a smartphone-based artificial intelligence (AI) system for anterior segment eye disease screening.
- Conditions
- Artifical Intelligence, Cataract, Pterygium, Keratopathy
- Trial name
- LENS (NCT07634913)
- Testing
- Smartphone-based on-device artificial intelligence system for anterior segment eye disease screening
- Where
- China
- Volunteers
- 3,000 people, healthy volunteers welcome
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
Dry Eye Syndromes, Meibomian Gland Dysfunction
Photobiomodulation With REd vs BluE Light (REBEL)
The use of photobiomodulation or low-level light therapy (LLLT) in the ophthalmic field stemmed from dermatology which has shown impact on skin blood flow and regeneration.
- Conditions
- Dry Eye Syndromes, Meibomian Gland Dysfunction, Blepharitis
- Trial name
- NCT06371300
- Testing
- Red LLLT, Blue LLLT
- Where
- 2 sites in New Zealand, United Kingdom
- Volunteers
- 36 people
- Sponsor
- Aston University